Page 15 - பிராங்க்ஃபர்ட் பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

20 April, 2021, 1:00 am People line up to receive AstraZeneca’s COVID-19 vaccine in Belfast, Northern Ireland. The United Kingdom has used the vaccine more than any other European country. Picture: Clodagh Kilcoyne/REUTERS What was a worrisome suspicion four weeks ago is now widely accepted: The AstraZeneca COVID-19 vaccine can, in very rare cases, cause a disorder characterised by dangerous blood clots and low platelet counts. In Europe, at least 222 suspected cases have been reported among 34 million people who have received their first dose of the vaccine. More than 30 have died. “Causality is more of a journey to certainty than a binary decision,” says Anthony Cox, an expert on pharmacovigilance at the University of Birmingham.

United kingdomMecklenburg vorpommernDavid spiegelhalterRolf marschalekAndreas greinacherPeter arlettGowthami arepallyAnthony coxCansino biologicsDuke university school of medicineWorld health organizationFrankfurt universityUniversity of birminghamVaccine allianceUniversity of cambridgeUniversity of greifswald